MAIA Biotechnology annual operating expenses
2021
2022
2023
2024
2025
MAIA Biotechnology Operating Expenses Growth & History (MAIA)
MAIA Biotechnology's operating expenses was $24.3M for fiscal 2025.
View full MAIA Biotechnology company overviewMAIA Biotechnology annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24.3M | $7.3M | +43.12% |
| 2024 | 2024-12-31 | $17.0M | −$3.2M | −15.98% |
| 2023 | 2023-12-31 | $20.2M | $4.0M | +24.77% |
| 2022 | 2022-12-31 | $16.2M | $8.4M | +107.74% |
| 2021 | 2021-12-31 | $7.8M | — | — |
MAIA Biotechnology quarterly operating expenses
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.3M | $3.2M | +61.00% |
| Q1 2026 | 2026-03-31 | $6.9M | $1.5M | +28.10% |
| Q4 2025 | 2025-12-31 | $4.3M | −$687,333 | −13.73% |
| Q3 2025 | 2025-09-30 | $9.4M | $5.2M | +123.49% |
| Q2 2025 | 2025-06-30 | $5.2M | $1.4M | +35.41% |
| Q1 2025 | 2025-03-31 | $5.4M | $1.5M | +37.39% |
| Q4 2024 | 2024-12-31 | $5.0M | −$1.4M | −21.53% |
| Q3 2024 | 2024-09-30 | $4.2M | −$767,175 | −15.48% |
| Q2 2024 | 2024-06-30 | $3.8M | −$849,384 | −18.21% |
| Q1 2024 | 2024-03-31 | $3.9M | −$235,374 | −5.63% |
| Q4 2023 | 2023-12-31 | $6.4M | $2.2M | +52.03% |
| Q3 2023 | 2023-09-30 | $5.0M | −$139,943 | −2.75% |
| Q2 2023 | 2023-06-30 | $4.7M | $1.2M | +35.52% |
| Q1 2023 | 2023-03-31 | $4.2M | $740,692 | +21.51% |
| Q4 2022 | 2022-12-31 | $4.2M | — | — |
| Q3 2022 | 2022-09-30 | $5.1M | $2.9M | +128.17% |
| Q2 2022 | 2022-06-30 | $3.4M | $1.9M | +128.97% |
| Q1 2022 | 2022-03-31 | $3.4M | — | — |
| Q3 2021 | 2021-09-30 | $2.2M | — | — |
| Q2 2021 | 2021-06-30 | $1.5M | — | — |
MAIA Biotechnology operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, MAIA Biotechnology's operating expenses increased from $7.8M to $24.3M, a change of $16.5M. The latest reported quarter, Q2 2026, shows $8.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MAIA Biotechnology source filings ↗